{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:59:22Z","timestamp":1791547162117,"version":"4.3.4"},"reference-count":32,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Objectives: Burkholderia cepacia complex (Bcc), a Gram-negative organism, is a well-recognized cause of hospital outbreaks, often linked to a contaminated shared source, such as multidose medications. In this study, we report an outbreak of Bcc infections in a tertiary care hospital, associated with the intrinsic contamination of a prepared solution used in interventional radiology (IR) procedures. Additionally, we provide a detailed explanation of the interventions implemented to control and interrupt the outbreak. Methods: Records from the infection control committee from 1 January 2023 to 31 October 2024 were screened to identify cases with Bcc growth in cultured blood, urine, or respiratory samples. Clinical and laboratory data were collected in March 2025. Bacterial identification was performed using conventional methods and MALDI-TOF (Bruker Daltonics, Bremen, Germany). Controls were matched to cases by ward, date of initial growth, and duration of hospitalization. Demographic and clinical data of these patients were systematically collected and analyzed. Microbiological cultures were obtained from environmental objects of concern and certain medications. Results: A total of 82 Burkholderia species were identified. We enrolled 77 cases and 77 matched controls. The source of contamination was identified in ready-to-use intravenous medications (remifentanil and magnesium preparations) in the IR department. These preparations were compounded in advance by the team and were used repeatedly. Although the outbreak originated from contaminated IV medications used in IR, secondary transmission likely affected 28 non-IR patients via fomites, shared environments, and possible lapses in isolation precautions. The mortality rate among the cases was 16.9%. Infection with Bcc was associated with prolonged intensive care unit stays (p = 0.018) and an extended overall hospitalization duration (p &lt; 0.001); however, it was not associated with increased mortality. The enforcement of contact precautions and comprehensive environmental decontamination successfully reduced the incidence of the Bcc outbreak. No pathogens were detected in cultures obtained after the disinfection. Conclusions: The hospital transmission of Bcc is likely driven by cross-contamination, invasive medical procedures, and the administration of contaminated medications. Implementing stringent infection control measures such as staff retraining, updated policies on medication use, enhanced environmental decontamination, and strict adherence to isolation precautions has proven effective in curbing the spread of virulent and transmissible Bcc.<\/jats:p>","DOI":"10.3390\/antibiotics14080774","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T07:45:11Z","timestamp":1754466311000},"page":"774","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A Nosocomial Outbreak of Burkholderia cepacia\u00a0complex Linked to Contaminated Intravenous Medications in a Tertiary Care Hospital"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4620-6755","authenticated-orcid":false,"given":"Hanife Nur","family":"Karakoc Parlayan","sequence":"first","affiliation":[{"name":"Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdevs","family":"Aksoy","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masite Nur","family":"Ozdemir","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-9101","authenticated-orcid":false,"given":"Esra","family":"Ozkaya","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurdal","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Jin, Y., Zhou, J., Zhou, J., Hu, M., Zhang, Q., Kong, N., Ren, H., Liang, L., and Yue, J. (2020). Genome-based classification of Burkholderia cepacia complex provides new insight into its taxonomic status. Biol. Direct, 15.","DOI":"10.1186\/s13062-020-0258-5"},{"key":"ref_2","first-page":"124","article-title":"Burkholderia cepacia\u2014Friend and foe","volume":"66","author":"Govan","year":"2000","journal-title":"ASM News"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1099\/jmm.0.000458","article-title":"Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients","volume":"66","author":"Kenna","year":"2017","journal-title":"J. Med. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3855\/jidc.124","article-title":"Nosocomial Burkholderia cepacia infections in a Turkish university hospital: A five-year surveillance","volume":"3","author":"Tunccan","year":"2009","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10096-007-0256-x","article-title":"Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro","volume":"26","author":"Caraher","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ajic.2013.12.015","article-title":"Successful outbreak investigation of Burkholderia cepacia complex bacteremia in intensive care patients","volume":"42","author":"Segonds","year":"2014","journal-title":"Am. J. Infect. Control"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1800540","DOI":"10.2807\/1560-7917.ES.2018.23.42.1800540","article-title":"Outbreak of Burkholderia cepacia complex infections associated with contaminated octenidine mouthwash solution, Germany, August to September 2018","volume":"23","author":"Becker","year":"2018","journal-title":"Eurosurveillance"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Tseng, S.-P., Tsai, W.-C., Liang, C.-Y., Lin, Y.-S., Huang, J.-W., Chang, C.-Y., Tyan, Y.-C., Lu, P.-L., and Eberl, L. (2014). The contribution of antibiotic resistance mechanisms in clinical burkholderia cepacia complex isolates: An emphasis on efflux pump activity. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0104986"},{"key":"ref_9","first-page":"1253","article-title":"A 17-Year Nationwide Study of Burkholderia cepacia Complex Bloodstream Infections Among Patients in the United States Veterans Health Administration","volume":"65","author":"Saade","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/S0036-46652014000100011","article-title":"Polyclonal outbreak of bloodstream infections caused by Burkholderia cepacia complex in hematology and bone marrow transplant outpatient units","volume":"56","author":"Boszczowski","year":"2014","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drup.2016.07.003","article-title":"Antibiotic resistance in Burkholderia species","volume":"28","author":"Rhodes","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jhin.2023.10.005","article-title":"Two consecutive outbreaks caused by chlorhexidine mouthwash contaminated with Burkholderia contaminans in a two-hospital tertiary care system","volume":"142","author":"Aldawood","year":"2023","journal-title":"J. Hosp. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13256-020-02415-8","article-title":"Investigation of Burkholderia cepacia complex bacteremia outbreak in a neonatal intensive care unit: A case series","volume":"14","author":"Bharara","year":"2020","journal-title":"J. Med. Case Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1017\/ice.2017.11","article-title":"An Outbreak of Burkholderia cepacian Complex Infections Associated with Contaminated Liquid Docusate","volume":"38","author":"Marquez","year":"2017","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s10096-020-03960-2","article-title":"Management and outcomes of Burkholderia cepacia complex bacteremia in patients without cystic fibrosis: A retrospective observational study","volume":"39","author":"Lee","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/519177","article-title":"Risk factors for Burkholderia cepacian complex bacteremia among intensive care unit patients without cystic fibrosis: A case-control study","volume":"28","author":"Bressler","year":"2007","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Shi, H., Chen, X., Chen, L., Zhu, B., Yan, W., and Ma, X. (2023). Burkholderia cepacia infection in children without cystic fibrosis: A clinical analysis of 50 cases. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1115877"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1440-1754.2007.01173.x","article-title":"Two outbreaks of Burkholderia cepacia nosocomial infection in a neonatal intensive care unit","volume":"44","author":"Lee","year":"2008","journal-title":"J. Paediatr. Child Health"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/660876","article-title":"An outbreak of Burkholderia cepacia complex associated with intrinsically contaminated nasal spray","volume":"32","author":"Dolan","year":"2011","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ajic.2017.11.018","article-title":"A multistate investigation of health care\u2013associated Burkholderia cepacia complex infections related to liquid docusate sodium contamination, January-October 2016","volume":"46","author":"Glowicz","year":"2018","journal-title":"Am. J. Infect. Control"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.58489\/2836-2276\/009","article-title":"Management of an Epidemic Outbreak of Burkholderia Cepacia in A Hospital in The North of Italy","volume":"2","author":"Bovolenta","year":"2023","journal-title":"J. Food Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ajic.2024.10.006","article-title":"A Burkholderia contaminans outbreak in an intensive care unit associated with contaminated bath solution: Control and microbiological findings","volume":"53","author":"Paraskevopoulos","year":"2025","journal-title":"Am. J. Infect. Control"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ormsby, J., Wagner, T., Gupta, R., Millson, T., and Phillips, B. (Am. J. Infect. Control, 2025). Safe injection, infusion, medication vial, and point-of-care testing practices in health care (2025), Am. J. Infect. Control, in press.","DOI":"10.1016\/j.ajic.2025.05.001"},{"key":"ref_24","unstructured":"World Health Organization (2016). Guidelines on Core Components of Infection Prevention and Control Programmes at the National and Acute Health Care Facility Level, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/9789241549929."},{"key":"ref_25","unstructured":"Centers for Disease Control and Prevention (CDC) (2025, July 25). Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings, Available online: https:\/\/www.cdc.gov\/infection-control\/hcp\/core-practices\/index.html."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100355","DOI":"10.1016\/j.ijregi.2024.03.010","article-title":"Epidemiology, microbiological, clinical characteristics, and outcome of Burkholderia cepacia complex infections in non-cystic fibrosis adult patients from Qatar","volume":"11","author":"Ibrahim","year":"2024","journal-title":"IJID Reg."},{"key":"ref_27","first-page":"121","article-title":"Nosocomial Burkholderia cepacia infection in a tertiary hospital; Five-year surveillance: A retrospective cross-sectional study","volume":"3","author":"Nazik","year":"2019","journal-title":"J. Surg. Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cheesbrough, M. (2005). District Laboratory Practice in Tropical Countries. Part 2, Cambridge University Press.","DOI":"10.1017\/CBO9780511581304"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e02459-20","DOI":"10.1128\/JCM.02459-20","article-title":"Evaluation of Optimal Blood Culture Incubation Time To Maximize Clinically Relevant Results from a Contemporary Blood Culture Instrument and Media System","volume":"59","author":"Ransom","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1128\/JCM.03383-12","article-title":"Quantitative Cultures of Bronchoscopically Obtained Specimens Should Be Performed for Optimal Management of Ventilator-Associated Pneumonia","volume":"51","author":"Baselski","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.egja.2016.03.004","article-title":"Ventilator associated pneumonia caused by extensive-drug resistant Acinetobacter species: Colistin is the remaining choice","volume":"32","author":"Hasanin","year":"2016","journal-title":"Egypt. J. Anaesth."},{"key":"ref_32","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2025, July 25). Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 15.0. Available online: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_15.0_Breakpoint_Tables.pdf."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/8\/774\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:19:31Z","timestamp":1760033971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/8\/774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["antibiotics14080774"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14080774","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}